Mast cell IL-4 expression is regulated by Ikaros and influences encephalitogenic Th1 responses in EAE

Journal of Clinical Investigation

Volumn 116, Issue 5, 2006, Pages 1327-1336

  Gregory, Gregory D ^a,b   Raju, Shveta S ^b   Winandy, Susan ^a   Brown, Melissa A ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IKAROS TRANSCRIPTION FACTOR; INTERLEUKIN 4; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GATA 1; TRANSCRIPTION FACTOR GATA 2; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; CELL DIFFERENTIATION; CELL HETEROGENEITY; CHROMATIN ASSEMBLY AND DISASSEMBLY; CONTROLLED STUDY; EXPERIMENTAL MODEL; IMMUNIZATION; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TH1 CELL; TH2 CELL;

ANIMALS; BASE SEQUENCE; CELL DIFFERENTIATION; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; GATA1 TRANSCRIPTION FACTOR; GATA2 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION; IKAROS TRANSCRIPTION FACTOR; INTERLEUKIN-4; MAST CELLS; MICE; MOLECULAR SEQUENCE DATA; TH1 CELLS;

EID: 33646407864     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI27227     Document Type: Article

References (62)

1. Weiss, D.L., and Brown, M.A. 2001. Regulation of IL-4 production in mast cells: a paradigm for cell-type-specific gene expression. Immunol. Rev. 179:35-47.
2. Biedermann, T., et al. 2001. IL-4 instructs TH1 responses and resistance to Leishmania major in susceptible BALB/c mice. Nat. Immunol. 2:1054-1060.
3. Min, B., et al. 2004. Basophils produce IL-4 and accumulate in tissues after infection with a Th2-inducing parasite. J. Exp. Med. 200:507-517.
4. Launois, P., et al. 2002. Rapid IL-4 production by Leishmania homolog of mammalian RACK1-reactive CD4(+) T cells in resistant mice treated once with anti-IL-12 or -IFN-gamma antibodies at the onset of infection with Leishmania major instructs Th2 cell development, resulting in nonhealing lesions. J. Immunol. 168:4628-4635.
5. Brown, M.A., et al. 1987. B cell stimulatory factor-1/interleukin-4 mRNA is expressed by normal and transformed mast cells. Cell. 50:809-818.
6. Noben-Trauth, N., Hu-Li, J., and Paul, W.E. 2002. IL-4 secreted from individual naive CD4+ T cells acts in an autocrine manner to induce Th2 differentiation. Eur. J. Immunol. 32:1428-1433.
7. Brown, M.A., and Hural, J. 1997. Functions of IL-4 and control of its expression. Crit. Rev. Immunol. 17:1-32.
8. Ansel, K.M., Lee, D.U., and Rao, A. 2003. An epigenetic view of helper T cell differentiation. Nat. Immunol. 4:616-623.
9. Ansel, K.M., et al. 2004. Deletion of a conserved Il4 silencer impairs T helper type 1-mediated immunity. Nat. Immunol. 5:1251-1259.
10. Lee, D.U., Agarwal, S., and Rao, A. 2002. Th2 lineage commitment and efficient IL-4 production involves extended demethylation of the IL-4 gene. Immunity. 16:649-660.
11. Solymar, D.C., Agarwal, S., Bassing, C.H., Alt, F.W., and Rao, A. 2002. A 3′ enhancer in the IL-4 gene regulates cytokine production by Th2 cells and mast cells. Immunity. 17:41-50.
12. Lee, G.R., Spilianakis, C.G., and Flavell, R.A. 2005. Hypersensitive site 7 of the TH2 locus control region is essential for expressing TH2 cytokine genes and for long-range intrachromosomal interactions. Nat. Immunol. 6:42-48.
13. Mohrs, M., et al. 2001. Deletion of a coordinate regulator of type 2 cytokine expression in mice. Nat. Immunol. 2:842-847.
14. Fields, P.E., Lee, G.R., Kim, S.T., Bartsevich, V.V., and Flavell, R.A. 2004. Th2-specific chromatin remodeling and enhancer activity in the th2 cytokine locus control region. Immunity. 21:865-876.
15. Grogan, J.L., et al. 2001. Early transcription and silencing of cytokine genes underlie polarization of T helper cell subsets. Immunity. 14:205-215.
16. Grogan, J.L., et al. 2003. Basal chromatin modification at the IL-4 gene in helper T cells. J. Immunol. 171:6672-6679.
17. Avni, O., et al. 2002. T(H) cell differentiation is accompanied by dynamic changes in histone acetylation of cytokine genes. Nat. Immunol. 3:643-651.
18. Sacks, D., and Noben-Trauth, N. 2002. The immunology of susceptibility and resistance to Leishmania major in mice. Nat. Rev. Immunol. 2:845-858.
19. Hondowicz, B.D., Park, A.Y., Elloso, M.M., and Scott, P. 2000. Maintenance of IL-12-responsive CD4+ T cells during a Th2 response in Leishmania major-infected mice. Eur. J. Immunol. 30:2007-2014.
20. Robbie-Ryan, M., and Brown, M. 2002. The role of mast cells in allergy and autoimmunity. Curr. Opin. Immunol. 14:728-733.
21. Nakae, S., et al. 2005. Mast cells enhance T cell activation: importance of mast cell-derived TNF. Proc. Natl. Acad. Sci. U. S. A. 102:6467-6472.
22. Gregory, G.D., Robbie-Ryan, M., Secor, V.H., Sabatino, J.J., Jr., and Brown, M.A. 2005. Mast cells are required for optimal autoreactive T cell responses in a murine model of multiple sclerosis. Eur. J. Immunol. 35:3478-3486.
23. Hochrein, H., et al. 2000. Interleukin (IL)-4 is a major regulatory cytokine governing bioactive IL-12 production by mouse and human dendritic cells. J. Exp. Med. 192:823-833.
24. Yao, Y., Li, W., Kaplan, M.H., and Chang, C.H. 2005. Interleukin (IL)-4 inhibits IL-10 to promote IL-12 production by dendritic cells. J. Exp. Med. 201:1899-1903.
25. Grewal, I.S., et al. 1996. Requirement for CD40 ligand in costimulation induction, T cell activation, and experimental allergic encephalomyelitis. Science. 273:1864-1867.
26. Yoshimoto, T., Bendelac, A., Hu-Li, J., and Paul, W.E. 1995. Defective IgE production by SJL mice is linked to the absence of CD4+, NK1.1+ T cells that promptly produce interleukin 4. Proc. Natl. Acad. Sci. U. S. A. 92:11931-11934.
27. Guo, L., et al. 2002. In TH2 cells the Il4 gene has a series of accessibility states associated with distinctive probabilities of IL-4 production. Proc. Natl. Acad. Sci. U. S. A. 99:10623-10628.
28. Loots, G.G., et al. 2000. Identification of a coordinate regulator of interleukins 4, 13, and 5 by cross-species sequence comparisons. Science. 288:136-140.
29. Kwan, M., Powell, D.R., Nachman, T.Y., and Brown, M.A. 2005. An intron GATA-binding site regulates chromatin accessibility and is essential for IL-4 gene expression in mast cells. Eur. J. Immunol. 35:1267-1274.
30. Henkel, G., et al. 1992. A DNase I-hypersensitive site in the second intron of the murine IL-4 gene defines a mast cell-specific enhancer. J. Immunol. 149:3239-3246.
31. Hural, J.A., Kwan, M., Henkel, G., Hock, M.B., and Brown, M.A. 2000. An intron transcriptional enhancer element regulates IL-4 gene locus accessibility in mast cells. J. Immunol. 165:3239-3249.
32. Sabbattini, P., et al. 2001. Binding of Ikaros to the lambda5 promoter silences transcription through a mechanism that does not require heterochromatin formation. EMBO J. 20:2812-2822.
33. Harker, N., et al. 2002. The CD8alpha gene locus is regulated by the Ikaros family of proteins. Mol. Cell. 10:1403-1415.
34. Asai, K., et al. 2001. Regulation of mast cell survival by IgE. Immunity. 14:791-800.
35. Galli, S.J., Nakae, S., and Tsai, M. 2005. Mast cells in the development of adaptive immune responses. Nat. Immunol. 6:135-142.
36. Gregory, G.D., and Brown, M.A. 2005. Mast cells in allergy and autoimmunity: implications for adaptive immunity. In Mast cells: methods and protocols. G. Krishnaswamy and D.S. Chi, editors. Humana Press Inc. Totowa, New Jersey, USA. 35-50.
37. Georgopoulos, K., et al. 1994. The Ikaros gene is required for the development of all lymphoid lineages. Cell. 79:143-156.
38. Migliaccio, A.R., et al. 2003. GATA-1 as a regulator of mast cell differentiation revealed by the phenotype of the GATA-1low mouse mutant. J. Exp. Med. 197:281-296.
39. Tsai, F.Y., and Orkin, S.H. 1997. Transcription factor GATA-2 is required for proliferation/survival of early hematopoietic cells and mast cell formation, but not for erythroid and myeloid terminal differentiation. Blood. 89:3636-3643.
40. Lee, H.J., et al. 2000. GATA-3 induces T helper cell type 2 (Th2) cytokine expression and chromatin remodeling in committed Th1 cells. J. Exp. Med. 192:105-115.
41. Yamashita, M., et al. 2004. Essential role of GATA3 for the maintenance of type 2 helper T (Th2) cytokine production and chromatin remodeling at the Th2 cytokine gene loci. J. Biol. Chem. 279:26983-26990.
42. Lee, G.R., Fields, P.E., and Flavell, R.A. 2001. Regulation of IL-4 gene expression by distal regulatory elements and GATA-3 at the chromatin level. Immunity. 14:447-459.
43. Monticelli, S., and Rao, A. 2002. NFAT1 and NFAT2 are positive regulators of IL-4 gene transcription. Eur. J. Immunol. 32:2971-2978.
44. Agarwal, S., Avni, O., and Rao, A. 2000. Cell-type-restricted binding of the transcription factor NFAT to a distal IL-4 enhancer in vivo. Immunity. 12:643-652.
45. Hutchins, A.S., et al. 2002. Gene silencing quantitatively controls the function of a developmental trans-activator. Mol. Cell. 10:81-91.
46. Makar, K.W., et al. 2003. Active recruitment of DNA methyltransferases regulates interleukin 4 in thymocytes and T cells. Nat. Immunol. 4:1183-1190.
47. Harigae, H., et al. 1998. Differential roles of GATA-1 and GATA-2 in growth and differentiation of mast cells. Genes Cells. 3:39-50.
48. Trinh, L.A., et al. 2001. Down-regulation of TDT transcription in CD4(+)CD8(+) thymocytes by Ikaros proteins in direct competition with an Ets activator. Genes Dev. 15:1817-1832.
49. Cobb, B.S., et al. 2000. Targeting of Ikaros to pericentromeric heterochromatin by direct DNA binding. Genes Dev. 14:2146-2160.
50. Kim, J., et al. 1999. Ikaros DNA-binding proteins direct formation of chromatin remodeling complexes in lymphocytes. Immunity. 10:345-355.
51. Guo, L., Hu-Li, J., and Paul, W.E. 2005. Probabilistic regulation in TH2 cells accounts for monoallelic expression of IL-4 and IL-13. Immunity. 23:89-99.
52. Guo, L., Hu-Li, J., and Paul, W.E. 2004. Probabilistic regulation of IL-4 production in Th2 cells: accessibility at the Il4 locus. Immunity. 20:193-203.
53. Cirillo, L.A., et al. 2002. Opening of compacted chromatin by early developmental transcription factors HNF3 (FoxA) and GATA-4. Mol. Cell. 9:279-289.
54. Yu, Y.L., Chiang, Y.J., and Yen, J.J. 2002. GATA factors are essential for transcription of the survival gene E4bp4 and the viability response of interleukin-3 in Ba/F3 hematopoietic cells. J. Biol. Chem. 277:27144-27153.
55. Jawdat, D.M., Albert, E.J., Rowden, G., Haidl, I.D., and Marshall, J.S. 2004. IgE-mediated mast cell activation induces Langerhans cell migration in vivo. J. Immunol. 173:5275-5282.
56. Lipoldova, M., et al. 2000. Susceptibility to Leishmania major infection in mice: multiple loci and heterogeneity of immunopathological phenotypes. Genes Immun. 1:200-206.
57. Beebe, A.M., Mauze, S., Schork, N.J., and Coffman, R.L. 1997. Serial backcross mapping of multiple loci associated with resistance to Leishmania major in mice. Immunity. 6:551-557.
58. Butterfield, R.J., et al. 1998. New genetic loci that control susceptibility and symptoms of experimental allergic encephalomyelitis in inbred mice. J. Immunol. 161:1860-1867.
59. Hock, M.B., and Brown, M.A. 2003. Nuclear factor of activated T cells 2 transactivation in mast cells: a novel isoform-specific transactivation domain confers unique FcepsilonRI responsiveness. J. Biol. Chem. 278:26695-26703.
60. Hahm, K., et al. 1994. The lymphoid transcription factor LyF-1 is encoded by specific, alternatively spliced mRNAs derived from the Ikaros gene. Mol. Cell. Biol. 14:7111-7123.
61. Supajatura, V., et al. 2002. Differential responses of mast cell Toll-like receptors 2 and 4 in allergy and innate immunity. J. Clin. Invest. 109:1351-1359. doi:10.1172/JCI200214704.
62. Heinemeyer, T., et al. 1998. Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL. Nucleic Acids Res. 26:362-367.